肝移植受者抗乙肝主动免疫构建与Th17及Treg细胞占比变化的相关性

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (694 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective To explore the correlations between the anti-hepatitis B active immune construction and the percentage of peripheral blood Th17 cells and Treg cells in liver transplantation recipients with hepatitis B-related liver disease, and provide theoretical support and practical experience for improving the success rate of construction.Methods One hundred and forty-four liver transplant recipients who were followed up in our hospital from February 2015 to June 2017 were enrolled according to the established criteria. These patients were randomly divided into four groups with informed consent(n=36): traditional group, traditional booster group, fast group and thymosin group. Each group was given a different anti-hepatitis B active immunization induction program. The difference between these groups in the anti-hepatitis B active immunization success rate was compared. The changes of the percentage of Th17 cells and Treg cells in lymphocytes and those of serum hepatitis B surface antibody (anti-HBs) titer were analyzed. The safety of vaccination was observed.Results The success rates of active immunization against hepatitis B in the four groups were 2.78% (1/36), 5.56% (2/36), 22.9% (8/35) and 34.3%(12/35)respectively, so the difference between these groups was statistically significant (P<0.05). The difference between the four groups in terms of increase of anti-HBs titers was significantly higher after the test (P<0.05). The percentage of Th17 cells decreased significantly in each group after the test. There was significant difference between the four groups (P<0.05). There was no significant difference in the percentage of Treg cells between these groups after the test (P>0.05). There was a significant positive correlation between the increase of -HBs and decline of Th17 (r=0.276, P=0.002) but no correlation with Treg changes was observed. Such biochemical parameters as blood routine, urine routine and liver function were not significantly different after the study.Conclusion For liver transplant recipients, it is safe and feasible to construct anti-hepatitis B active immunity via proper inoculation with hepatitis B vaccines. The lower expression of Th17 cells may promote the immune construction against hepatitis B and Treg cells seem to have no effect on the construction.

Key words： liver transplantation active immunity against hepatitis B construction Th17 cell Treg cell

Received: 13 November 2018

ZTFLH:

R617

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DOU Gufeng
	ZHU Xiongwei
	CHEN Xinguo
	LU Shuchun
	LI Wei
	HOU Na
	XIAO Hua
	YOU Bo
	SONG Jun
	and NIU Yujian

Cite this article:

DOU Gufeng,ZHU Xiongwei,CHEN Xinguo等. Relationships between construction of active immunization against hepatitis B and the changes of Th17 and Treg cells in liver transplant recipients[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(2): 105-108.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I2/105

[1]	高银杰, 刘振文, 张敏,等. 乙肝疫苗预防相关性肝移植后乙肝复发的临床观察[J]. 武警医学, 2013, 24(11):935-938.
[2]	张国民, 孙校金, 王富珍,等. 中国18～59岁人群乙型病毒性肝炎流行病学特征分析及乙型肝炎疫苗免疫策略探讨[J]. 中国疫苗和免疫, 2013,19(3):266-270.
[3]	Wang S H, Loh P Y, Lin T L,et al. Active immunization for prevention of de novo HBV infection after adult living donor liver transplantation with HBc(+) graft.[J]. Liver Transpl, 2017, 23(10):1266-1272.
[4]	王维伟, 王麟, 朱雄伟,等. 乙型肝炎疫苗不同接种方案对肝移植受者接种成功率及Th2细胞变化的影响[J]. 中国疫苗和免疫, 2017, 23(2):144-147.
[5]	Feng Lijuan, Niu Yujian, Chen Hong, et al. Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients [J]. Hepatol Res, 2013, 43(5): 495-501.
[6]	杜立颖, 冯仁青. 流式细胞术[M]. 2版.北京:北京大学出版社, 2014:187-188.
[7]	郭源, 王文涛, 李自强,等. 乙肝疫苗接种:乙肝相关肝移植受者预防乙肝复发的新策略[J]. 中华肝胆外科杂志, 2015, 21(10):668-670.
[8]	王乐天, 沈中阳, 牛玉坚,等. 核苷类似物联合乙肝免疫球蛋白预防肝移植后乙肝病毒再感染的远期效果[J]. 武警医学, 2010, 11(2):939-940.
[9]	牛玉坚. 乙型肝炎免疫球蛋白在预防肝移植后乙型肝炎复发中的作用[J]. 中华器官移植杂志, 2006, 27(12):763-764.
[10]	冯丽娟,牛玉坚,臧运金,等.乙肝相关性肝病肝移植术后乙肝疫苗接种研究进展[J].中华医学杂志, 2012,92(7):499-501.
[11]	王垒,范林, 彭贵主,等. 乙型肝炎免疫球蛋白在肝移植术后乙型肝炎复发防治中的应用[J]. 中华肝胆外科杂志,2017,23(7):494-498.
[12]	Gagliani N, Vesely M C A, IsepponA, et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation[J]. Nature, 2015, 523(7559):221-225.
[13]	罗丽君, 徐成高, 侍晓云. Th17细胞的研究进展及与人类疾病的关系[J]. 武警医学, 2015, 26(10):1059-1061.
[14]	Kang S W, Kim S H, Lee N, et al. 1,25-Dihyroxyvitam in D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region[J]. J Immuno1, 2012, 188(11):5276-5282.
[15]	Harrington L E, Mangan P R, Weaver C T. Expanding the effector CD4T-cell repertoire: the Th17 lineage [J]. CurrOpin Immunol, 2006, 18(3):349-356.
[16]	Wang J M, Ma C J, Li G Y, et al. Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection[J]. Vaccine, 2013, 31(18):2238-2245.
[17]	Xin L, Li Y, Soong L. Role of interleukin-1β in activating the CD11chigh CD45RB-dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo[J]. Infect Immun, 2007, 75(10):5018-5026.
[18]	Du X, Zhao B, Li J, et al. Astragalus, polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice[J]. Int Immunopharmacol, 2012, 14(4):463-470.
[19]	Wang S, Qiu L, Liu G, et al. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice[J]. Vaccine, 2011, 29(37):6342-6351.
[20]	Chen X, Oppenheim J J, Howard O M. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice[J]. J LeukocBiol, 2005, 78(1):114-121.